Do Sucralose and Stevia Alter Your Gut Microbiome Across Generations? What the New Mouse Research Shows

How Do Sucralose and Stevia Compare in Their Multigenerational Effects?

A 2026 study in Frontiers in Nutrition found that both sucralose and stevia — two of the world's most widely consumed zero-calorie sweeteners — altered the gut microbiome, reduced beneficial microbial metabolites, and changed the activity of genes linked to metabolism and inflammation in mice. Some of those biological changes echoed into generations that never consumed the sweeteners at all.

The research, led by Dr. Francisca Concha Celume of the Universidad de Chile and published in April 2026, is among the first to track the multigenerational biological footprint of non-nutritive sweeteners (NNS) under controlled laboratory conditions. It does not prove that sweeteners cause disease in humans, but it raises pointed questions about what "zero-calorie" actually means for long-term metabolic health.

How Do Sucralose and Stevia Compare in Their Multigenerational Effects?

The table below summarises the key findings across the three generations studied (F0 = sweetener-exposed parents; F1 = first-generation offspring; F2 = second-generation offspring, neither F1 nor F2 consumed sweeteners directly):

Outcome Measured	Sucralose (F0 exposed)	Stevia (F0 exposed)	Control (water only)
Gut microbiome diversity	Increased, with more pathogenic species	Increased	Baseline
Short-chain fatty acids (F0)	Reduced	Reduced	Normal
Short-chain fatty acids (F1 & F2)	Reduced in both generations	Reduced in both generations	Normal
Glucose tolerance impairment (F1)	Impaired in males	Not detected	None
Elevated fasting blood sugar (F2)	Males affected	Females affected	None
Pro-inflammatory gene expression	Elevated; persisted 2 generations	Elevated; faded after 1 generation	Baseline
Metabolic gene expression	Suppressed; persisted 2 generations	Suppressed; faded after 1 generation	Baseline
Overall persistence of effects	Stronger and more consistent	Weaker, limited to F1	N/A

Sources: Frontiers in Nutrition (full paper, PMC); ScienceDaily summary; News-Medical.net.

The contrast is stark: sucralose left a biological imprint still detectable two generations after the original exposure ended, while stevia's effects, though real, were largely confined to the first generation.

What Exactly Did the Researchers Do?

The study was a three-generation controlled dietary exposure experiment. Forty-seven male and female mice (the F0, or parental, generation) were divided into three groups at four weeks of age. One group received plain water; the other two received water supplemented with either sucralose or stevia at doses designed to approximate what a human might reasonably consume as part of a normal diet.

After six weeks, mice within each group were bred. Their offspring — the F1 generation — received only plain water and standard chow from weaning onwards. Unrelated F1 mice from the same groups were then crossed to produce the F2 generation, which also received no sweeteners.

At 20 weeks of age, mice from all three generations were assessed for:

Oral glucose tolerance — a standard test for insulin resistance and early diabetes risk
Fecal microbiome composition — via analysis of stool samples
Short-chain fatty acid (SCFA) concentrations, measured from fecal samples
Expression of five genes in the liver and intestines, selected for their roles in inflammation, gut barrier integrity, and metabolic regulation

As Concha explained to ScienceDaily, animal models were chosen precisely because they allow tight control of environmental variables and enable researchers to follow multiple generations within a practical timeframe — something impossible to replicate in human trials over equivalent biological timescales.

What Are Short-Chain Fatty Acids and Why Do They Matter Here?

Short-chain fatty acids (SCFAs) — primarily acetate, propionate, and butyrate — are produced when gut bacteria ferment dietary fibre. They are not merely metabolic byproducts. SCFAs regulate immune responses, maintain the integrity of the gut lining, influence insulin sensitivity, and can affect gene expression through epigenetic mechanisms.

That last point is central to the study's significance. Research published in Diseases (PMC, 2025) has documented that artificial sweeteners broadly disrupt gut microbial communities. The Universidad de Chile team hypothesised that this disruption reduces SCFA output, which in turn could alter gene expression patterns in ways that are heritable — passed from parent to offspring through epigenetic rather than genetic changes.

Both sucralose- and stevia-exposed mice had lower SCFA concentrations than controls. Crucially, reduced SCFA levels were also found in the F1 and F2 generations — offspring who had never swallowed a single milligram of either sweetener. This pattern is consistent with, though does not definitively prove, an epigenetic transmission mechanism.

What Happened to Blood Sugar Regulation Across Generations?

The glucose tolerance findings shifted in a sex-specific pattern that the researchers themselves described as unexpected.

In the F1 generation, impaired glucose tolerance appeared only in males descended from sucralose-consuming parents. The stevia group's F1 offspring showed no significant glucose impairment at this stage.

By the F2 generation, the picture changed again. Elevated fasting blood sugar was detected in male descendants of the sucralose group and female descendants of the stevia group. This cross-generational, sex-differentiated pattern suggests the mechanisms at work are not straightforward dose-response relationships but something more complex — possibly involving differential epigenetic programming in male and female reproductive cells.

As Concha told Frontiers: "The changes we observed in glucose tolerance and gene expression could be interpreted as early biological signals related to metabolic or inflammatory processes. The animals did not develop diabetes. Instead, what we observed were subtle changes in how the body regulates glucose and in the activity of genes associated with inflammation and metabolic regulation."

The researchers frame these as signals of increased susceptibility, not confirmed disease outcomes. A mouse that shows impaired glucose tolerance is not a diabetic mouse — but it may be one that would become diabetic faster under additional metabolic stress, such as a high-fat diet.

How Did the Gut Microbiome Change, and Is More Diversity Always Good?

Both sweetener groups developed more diverse fecal microbiomes than controls — a finding that sounds positive on the surface, since microbiome diversity is often associated with better health. But the composition of that diversity matters enormously.

High diversity is generally considered beneficial when it reflects a broad community of health-promoting species. When diversity increases because pathogenic or opportunistic species proliferate while beneficial species decline, the net effect can be harmful.

In the sucralose group, the shift in microbiome composition was more pronounced and more concerning: the study found greater numbers of pathogenic bacteria and fewer beneficial species compared to both the stevia group and controls. This pattern — higher diversity but worse composition — is sometimes described in the microbiome literature as dysbiosis, and it aligns with the lower SCFA concentrations observed. The stevia group also showed microbiome changes, but they were less severe and less persistent. By the F2 generation, sucralose's microbiome legacy was still detectable; stevia's was fading.

What Genes Were Affected, and What Do They Do?

The research team examined five genes in liver and intestinal tissue, chosen to represent three biological domains:

Inflammation — genes that regulate the body's inflammatory response
Gut barrier integrity — genes involved in maintaining the tight junctions between intestinal cells that prevent harmful substances from leaking into the bloodstream
Metabolic regulation — genes governing how cells process glucose, fats, and other nutrients

Sucralose exposure was associated with increased expression of pro-inflammatory genes and decreased expression of metabolic genes in the F0 mice, and those changes were still detectable in F1 and F2 animals. Stevia also altered gene expression in F0 mice, but the changes were smaller in magnitude and were not consistently observed beyond the F1 generation.

The Frontiers press release notes that the scientists interpreted these gene expression changes as potential epigenetic influences — modifications to how genes are read, rather than changes to the DNA sequence itself — that could be transmitted through reproductive cells from one generation to the next.

This is a plausible mechanism, but the study does not directly demonstrate epigenetic inheritance. Proving that requires additional experimental steps, such as showing that specific epigenetic marks (DNA methylation patterns, for example) are present in both parents and offspring at the same gene locations. That work remains to be done.

How Should We Read This Research — What Are Its Limits?

Several important caveats apply, and the researchers are upfront about them.

It is a mouse study. Mice and humans share many metabolic pathways, but they are not identical. Mice metabolise sucralose differently from humans — a larger proportion of ingested sucralose is absorbed in the mouse gut than in the human gut. Whether the same multigenerational effects would occur in humans at comparable exposure levels is genuinely unknown.

The sample size is also modest. Forty-seven mice across three groups, then bred for two generations, produces relatively small subgroup numbers by the F2 generation. Sex-specific effects in particular — like the finding that F2 males from sucralose parents and F2 females from stevia parents showed elevated fasting blood sugar — need replication in larger cohorts before they can be treated as solid.

Causation is not established. The study shows associations between sweetener exposure in parents and biological changes in offspring; it does not rule out confounding factors, and the epigenetic transmission mechanism is inferred rather than directly demonstrated. The doses were designed to be human-relevant, but scaling doses from mice to humans involves assumptions about body surface area, metabolic rate, and gut transit time that introduce their own uncertainty.

As Concha put it: "The goal of this research is not to create alarm, but to highlight the need for further investigation. It may be reasonable to consider moderation in the consumption of these additives and to continue studying their long-term biological effects."

Moderation and further study — not prohibition — is the appropriate takeaway at this stage of the evidence.

What Does the Broader Literature Say About Sweeteners and Gut Health?

This study does not exist in isolation. A 2025 review published in Diseases (PMC) characterised artificial sweeteners as "a double-edged sword for gut microbiome," documenting evidence that sweeteners including sucralose, saccharin, and aspartame can alter microbial composition, reduce SCFA production, and compromise gut barrier function. That review covered human and animal data and found that the direction and magnitude of effects varied considerably by sweetener type, dose, and individual microbiome baseline.

A separate 2024 randomised controlled trial, also covered by ScienceDaily, found that replacing sugar with sweeteners did not increase appetite and did help reduce post-meal blood sugar — a finding that cuts in the other direction. Sweeteners are not uniformly harmful, and for people managing blood sugar or caloric intake, they may still offer net benefits depending on individual context.

The WHO issued a guideline in 2023 suggesting that long-term NNS use may be associated with a higher risk of cardiovascular disease and type 2 diabetes, though that guidance was based on observational data and acknowledged significant uncertainty. NNS consumption has grown substantially across all age groups, including women of childbearing age — as noted by News-Medical.net — the demographic whose sweetener intake would be most directly relevant to the multigenerational findings of this new study.

What Does This Mean for People Who Use Sweeteners Regularly?

The honest answer is: not enough to change behaviour dramatically, but enough to warrant attention — particularly for people who consume sucralose or stevia daily and are planning to have children.

The study's findings are preliminary evidence of multigenerational biological effects in a controlled animal model, not clinical guidance. No regulatory body has changed its position on sucralose or stevia safety based on this research, and both sweeteners remain approved for use in India and most other jurisdictions.

That said, a few practical considerations follow from the data.

Sucralose appears to carry a heavier biological burden than stevia in this model. If you are choosing between the two for regular use, the current evidence — still thin and animal-based — gives stevia a marginal edge in terms of multigenerational metabolic risk.

The effects observed were calibrated to human-equivalent consumption levels. Occasional use is unlikely to produce the sustained microbiome disruption seen in mice that consumed sweeteners for 16 continuous weeks.

The gut microbiome is also modifiable. Even if sweetener use has shifted your microbial composition, dietary interventions — increased fibre, fermented foods, prebiotic-rich vegetables — can support SCFA-producing bacteria. Articles like our guide on best gas relief supplements in India and berberine for insulin resistance explore some of the evidence-based options for supporting gut and metabolic health.

For people managing blood sugar — a growing concern in India, where type 2 diabetes prevalence is among the highest globally — the calculus remains complicated. Replacing sugar with sweeteners may still be the lesser metabolic harm in the short term, even if the long-term picture is murkier than the "zero-calorie" label implies.

What Research Comes Next?

The Universidad de Chile team's study opens several questions that future research will need to address.

Direct epigenetic mapping is one priority. Do the offspring of sweetener-exposed mice carry identifiable epigenetic marks — altered DNA methylation or histone modification patterns — at the same gene loci where expression changes were observed? If yes, that would substantially strengthen the multigenerational transmission hypothesis.

Human cohort data would be the most informative next step and the hardest to conduct rigorously: prospective studies tracking NNS consumption in women before and during pregnancy, then following offspring gut microbiome composition and metabolic markers through childhood.

Dose-response clarity is also needed. The current study used a single human-equivalent dose. Understanding whether lower doses produce attenuated effects, or whether there is a threshold below which multigenerational effects disappear, is essential for practical guidance.

Sucralose and stevia are chemically very different compounds — sucralose is a chlorinated derivative of sucrose; stevia is a plant-derived glycoside. Understanding why they produce different multigenerational profiles could reveal which molecular properties drive gut disruption and which do not, informing the design of safer alternatives.

The field of nutritional epigenetics — the study of how dietary exposures alter heritable patterns of gene expression without changing the underlying DNA sequence — is still young. This study is a meaningful contribution to it, but it is one data point in what will need to be a much larger body of evidence before clinical recommendations can change.

For now, the most defensible position is the one the researchers themselves articulate: moderation, continued investigation, and a healthy scepticism toward the assumption that "zero calories" means "zero biological consequence."